MedTrace Logo

BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)

NCT07786012 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-08-26

No results posted yet for this study

Summary

In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.

Conditions

  • Cesarean Delivery

Interventions

DRUG

buprenorphine

60 mcg buprenorphine intrathecal

DRUG

morphine

125mcg morphine intrathecal

Sponsors & Collaborators

Principal Investigators

  • Daniel Katz · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2028-08-31
Completion
2028-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07786012 on ClinicalTrials.gov